Free tool
FAERS Monitor: Mounjaro
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 215866 or its brand name (Mounjaro, Tirzepatide). Reports on generic versions are filed under their own applications.
Reports
100,728
Serious
27,362
27% of reports
Hospitalization
9,837
Death reported
887
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- incorrect dose administered17,484
- nausea10,241
- injection site pain9,528
- off label use8,262
- diarrhoea6,368
- vomiting5,525
- extra dose administered5,273
- constipation3,915
- injection site haemorrhage3,644
- product dose omission issue3,451
- injection site erythema3,219
- blood glucose increased3,088
- drug ineffective2,768
- fatigue2,759
- decreased appetite2,531
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 24 |
| 2020 | 30 |
| 2021 | 32 |
| 2022 | 5,039 |
| 2023 | 20,764 |
| 2024 | 22,632 |
| 2025 | 31,711 |
| 2026 | 20,481 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,953,431 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| extra dose administeredSignal | 5,273 | 31.1 | 30.2 | 133,848 |
| incorrect dose administeredSignal | 17,484 | 17.2 | 17.0 | 249,636 |
| injection site haemorrhageSignal | 3,644 | 9.9 | 9.6 | 28,042 |
| injection site painSignal | 9,528 | 6.7 | 6.5 | 45,077 |
| injection site erythemaSignal | 3,219 | 5.5 | 5.3 | 11,719 |
| constipationSignal | 3,915 | 3.8 | 3.7 | 8,008 |
| blood glucose increasedSignal | 3,088 | 3.5 | 3.3 | 5,366 |
| nauseaSignal | 10,241 | 2.7 | 2.7 | 11,461 |
| vomitingSignal | 5,525 | 2.5 | 2.4 | 4,889 |
| product dose omission issueSignal | 3,451 | 2.5 | 2.4 | 3,018 |
| decreased appetiteSignal | 2,531 | 2.3 | 2.2 | 1,837 |
| diarrhoeaSignal | 6,368 | 2.1 | 2.0 | 3,599 |
| off label use | 8,262 | 2.0 | 1.9 | 4,138 |
| fatigue | 2,759 | 0.7 | 0.7 | 263 |
| drug ineffective | 2,768 | 0.4 | 0.4 | 2,132 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.